A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia - Homburg,R.; West,C.; Brownell,J.; Jacobs,H.S. (Clin Endocrinol (Oxf), 1990)